The purchase shouldn’t surprise too many of you. Often times, Lanny will find a great dividend growth stock on a discount and sell me on the fact that the company is a buy. Well, this time was definitely one of those instances and I followed his lead in purchasing shares in this dividend growth stock. Time to see why I purchased shares in CVS Health Corp (CVS).
This morning, I was updating my portfolio sipping on a nice, warm cup of coffee updating my portfolio with all the madness/dividend income that has trickled in so far in March. There is a reason why the third quarter of the month is everyone’s favorite dividend month, right? After re-reading Lanny’s article about updating you portfolio’s P/E Ratio on a regular basis, I became inspired to review one of the stocks that I have considered selling for a while now. I’ve been debating if the stock still fits the characteristics I look for in a dividend growth stock, so I thought today would be a perfect day to re-run Schlumberger (SLB) through the Dividend Diplomats Stock Screener and see if action is necessary.
The first quarter behind us. Boy did the stock market take us on a quite a ride for the first quarter. Plenty of stocks to consider/grab in the first part of the quarter and….well…the stock market has not stopped climbing for months. Regardless of how Mr. Market performed, I wanted to take this opportunity to reflect on the first three months and see how I am progressing towards the 2016 goals that I set back in December. It is still early on, so I can easily tweak where necessary! Now, lets dive into my Q1 2016 goals review.
The Diplomats were back and at it again! Loving the end of February, the turmoil and the continuous short-term declines in the market that unlocks opportunity in just a blink of an eye. We were on the hot seat this week, and boy did we take some advantage of market fluctuations. Wednesday was a well placed trade on a wonderful asset management company – T. Rowe Price (TROW). Let’s see how, when and what led the purchase by both of us!
I couldn’t sit on the sidelines too long. After a strong month of purchased in January, which saw me add to my current stakes in ADM and CZNC, I wanted to keep the momentum rolling. At the end of my January dividend income article, I mentioned that I purchased a stock but haven’t disclosed the purchase yet to the community. Well, that is about to change. Last week I unloaded some capital and purchased a stake in Pfizer (PFE). Let’s see why!
Well…well…well….it looks like January ended the same way it started for me….with buying a stock! At the beginning of the month I was able to add to my stake in ADM, a darling of the dividend investors community of late due to drop in stock price over the last few months. And after the boom that occurred at the end of the month, I was happy I purchased shares in ADM when I did. After my ADM purchase, there was a little bit of a lull period when I sat on the sidelines as the madness unfolded. Until the end of the month, when I accidentally stumbled on a great opportunity. You guessed it, I purchased some additional shares of one of my Roth holdings Citizens and Northern Corporation (CZNC). See why I purchased more shares in this community bank.
This post will be an investing lesson regarding a certain investing topic that dividend investors will occasionally use when they discuss performance and metrics. It is similar to your yield and is a huge proponent for how long you hold onto an investment, the activities that happen within that investment, as well as the pros and cons of measuring such a metric. The topic that I’d like to discuss today is the Yield on Cost or, as I like to call it – The YOC! And no… this is not the same thing as in the NFL or YAC (Yards after catch), close though! Let’s talk about The YOC! Continue reading